Related references
Note: Only part of the references are listed.IncreasedABCC2expression predicts cisplatin resistance in non-small cell lung cancer
Yun Chen et al.
CELL BIOCHEMISTRY AND FUNCTION (2021)
Pathogenesis and therapeutic strategy in platinum resistance lung cancer
Panpan Lv et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1
Mustafa Emre Ercin et al.
BALKAN MEDICAL JOURNAL (2020)
Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy
Hong Wang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Jiabei Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Cancer statistics for adolescents and young adults, 2020
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription
Yunyao Liu et al.
ONCOGENE (2020)
PERFTORAN (VIDAPHOR)-INTRODUCTION TO WESTERN MEDICINE
Gary W. Latson
SHOCK (2019)
Blocking OLFM4/HIF-1 axis alleviates hypoxia-induced invasion, epithelial-mesenchymal transition, and chemotherapy resistance in non-small-cell lung cancer
Xian-Zheng Gao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Luis M. Seijo et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer A Review
Kathryn C. Arbour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Fighting Hypoxia to Improve PDT
Ludivine Larue et al.
PHARMACEUTICALS (2019)
Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and sternness
Jingjing Wang et al.
CANCER LETTERS (2018)
Improvement of islet function and survival by integration of perfluorodecalin into microcapsules in vivo and in vitro
Sang-Ho Lee et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2018)
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1 alpha and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
Christophe Deben et al.
CANCERS (2018)
Plasma membrane changes during programmed cell deaths
Yingying Zhang et al.
CELL RESEARCH (2018)
Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression
Terumasa Sowa et al.
CANCER MEDICINE (2017)
Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells
Mia C. Akerfeldt et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Molecular mechanisms of hypoxia in cancer
Amarnath Challapalli et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Histological grading in lung cancer: one system for all or separate systems for each histological type?
William D. Travis et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Cisplatin resistance and opportunities for precision medicine
Lauren Amable
PHARMACOLOGICAL RESEARCH (2016)
Hypoxia-inducible factor 1 and breast cancer metastasis
Zhao-ji Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy
Yuhao Cheng et al.
NATURE COMMUNICATIONS (2015)
SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
Dong Hoon Shin et al.
CANCER RESEARCH (2014)
Hypoxia-regulated microRNAs in human cancer
Guomin Shen et al.
ACTA PHARMACOLOGICA SINICA (2013)
DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
Wynand P. Roos et al.
CANCER LETTERS (2013)
Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
Qi Zhang et al.
CARCINOGENESIS (2013)
Valproic acid overcomes hypoxia-induced resistance to apoptosis
Simon Cipro et al.
ONCOLOGY REPORTS (2012)
Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells
Christoph Wohlkoenig et al.
CANCER LETTERS (2011)
Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions
Natalya Rapoport et al.
JOURNAL OF CONTROLLED RELEASE (2011)
MicroRNA-210 A unique and pleiotropic hypoxamir
Stephen Y. Chan et al.
CELL CYCLE (2010)
HIF-1 and HIF-2 transcription factors - Similar but not identical
Agnieszka Loboda et al.
MOLECULES AND CELLS (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
Brian G. Blair et al.
CLINICAL CANCER RESEARCH (2009)
ABC Transporters as Potential Targets for Modulation of Drug Resistance
L. Gatti et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
Richard Sullivan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Analysis of cycloheximide-induced apoptosis in human leukocytes: Fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide
Dejan Baskic et al.
CELL BIOLOGY INTERNATIONAL (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The comet assay for DNA damage and repair - Principles, applications, and limitations
AR Collins
MOLECULAR BIOTECHNOLOGY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines
ZJ Yang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Share Paper
